NYSE$ECL

Ecolab Inc · Q2 2020 earnings

Q2 2020 earnings · · Investor relations

Briefing

Ecolab's performance was significantly impacted by COVID-19, with strong growth in Healthcare and Life Sciences offset by declines in Institutional and Other segments. The separation of ChampionX business also affected the results.

Ecolab's second quarter results were impacted by COVID-19, with a 15% decrease in reported sales. Adjusted EPS from continuing operations was $0.65, a 49% decrease. The Healthcare and Life Sciences segment showed strong growth, while the Institutional segment was heavily impacted by COVID-19 shutdowns.

  • Reported sales from continuing operations decreased by 15%.
  • Reported diluted EPS from continuing operations decreased by 63% to $0.44.
  • Adjusted diluted EPS from continuing operations decreased by 49% to $0.65.
  • Free cash flow from continuing operations was $229 million.

Headline financials

Total Revenue

$2.69B

Previous: $3.76B-28.6%
EPS (adj)

$0.65

Previous: $1.42-54.2%
Capital Expenditures

-$251M

Previous: -$371M+32.4%
Free Cash Flow

-$2.28B

Previous: $1.7M-134247.1%
Net Income

-$2.03B

Previous: $372M-645.4%
Operating Income

$192M

Previous: $499M-61.5%
Gross Profit

$1.05B

Previous: $1.55B-32.3%
Cash & Equivalents

$1.37B

Previous: $85.7M+1497.4%
Total Assets

$18.1B

Previous: $20.8B-13.2%
Stock-Based Comp

$26.3M

Previous: $27.3M-3.7%

Revenue & EPS history

Ecolab · Revenue · Quarterly

$2.69B

Q2 2020-28.6%vs Q2 2019
Beat estimate in 11 of 16 quarters(69%)
ActualEstimate

Revenue by segment

Ecolab · $950M total across 2 segments · Q2 2020

  • Global Institutional & Specialty
    $708M
  • Global Pest Elimination
    $242M

Forward guidance

Due to the uncertain outlook regarding the full extent of COVID-19’s impact on the global economy and its longevity, Ecolab is not providing either quarterly or annual earnings forecasts.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q2 2020

Historical avgQ2 2020

+0.1%

Avg return

Earnings day

-0.0%

Avg return

5 days after

+1.3%

Avg return

30 days after

58%

42 / 73 earnings

Positive

+10.9%

Q4 2022

Best reaction

-12.6%

Q3 2022

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+0.8%-3.1%-3.1%
Q4 2025+4.0%+3.8%-4.3%
Q3 2025-4.1%-8.3%-1.7%
Q2 2025+0.4%+2.9%+1.8%
Q1 2025+3.3%+6.8%+10.6%
Q4 2024+6.2%+7.6%+2.1%
Q3 2024-1.5%-4.6%-3.4%
Q2 2024-6.9%-4.3%+0.9%
Q1 2024+1.5%+2.6%+3.2%
Q4 2023+6.9%+1.7%-1.4%
Q3 2023+5.1%+9.8%+20.5%
Q2 2023+1.0%-0.3%+0.4%
Q1 2023+2.7%+2.9%+0.2%
Q4 2022+10.9%+9.8%+7.4%
Q3 2022-12.6%-14.2%-3.3%
Q2 2022-1.3%+1.5%+5.0%
Q1 2022-2.9%-3.6%-6.5%
Q4 2021-0.1%-2.3%-6.1%
Q3 2021-0.2%+0.3%+4.4%
Q2 2021-0.0%+0.8%+1.8%
Q1 2021-2.1%-1.2%-4.7%
Q4 2020-5.0%-5.4%-4.7%
Q3 2020-6.5%-7.4%+10.0%
Q2 2020-8.1%-11.8%-6.8%
Q1 2020+5.4%+1.3%+12.7%
Q4 2019+1.4%+0.1%-23.0%
Q3 2019+1.1%-0.3%-2.4%
Q2 2019+0.6%-0.3%+3.2%
Q1 2019-1.1%+0.3%-0.6%
Q4 2018+1.1%+2.2%+7.5%
Q3 2018+4.5%+5.5%+8.1%
Q2 2018+2.8%+4.5%+6.7%
Q1 2018-0.4%+0.4%-1.5%
Q4 2017-1.2%-0.5%+2.0%
Q3 2017+0.3%+0.4%+3.8%
Q2 2017+0.9%+0.9%+1.2%
Q1 2017-2.8%-2.2%+3.5%
Q4 2016-0.7%+1.3%+0.2%
Q3 2016-1.9%-3.1%+3.8%
Q2 2016+2.3%+3.4%+3.7%
Q1 2016+0.9%
Q4 2015-5.5%
Q3 2015-0.3%
Q2 2015+6.4%
Q1 2015-1.4%
Q4 2014+3.8%
Q3 2014-2.2%
Q2 2014-1.5%
Q1 2014-0.9%
Q4 2013+0.5%
Q3 2013+3.0%
Q2 2013+0.0%
Q1 2013+1.2%
Q4 2012+6.2%
Q3 2012+0.1%
Q2 2012-3.6%
Q1 2012+1.0%
Q4 2011-4.2%
Q3 2011-4.6%
Q2 2011-3.5%
Q1 2011+2.5%
Q4 2010+2.4%
Q3 2010+0.3%
Q2 2010-0.7%
Q1 2009-1.7%
Q1 2010+1.2%
Q4 2007+0.5%
Q4 2009+0.5%
Q3 2009+2.2%
Q3 2008+2.2%
Q2 2009+0.0%
Q2 2008+0.0%
Q4 2008+0.0%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro